{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:48:16Z","timestamp":1791236896647,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.pharmthera.2004.08.011","type":"journal-article","created":{"date-parts":[[2004,10,24]],"date-time":"2004-10-24T03:07:07Z","timestamp":1098587227000},"page":"85-93","source":"Crossref","is-referenced-by-count":101,"title":["C-type natriuretic peptide in vascular physiology and disease"],"prefix":"10.1016","volume":"105","author":[{"given":"Ramona S.","family":"Scotland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Ahluwalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian J.","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.pharmthera.2004.08.011_bib1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00004872-199715080-00004","article-title":"Atrial natriuretic peptide-C receptor and membrane signalling in hypertension","volume":"15","author":"Anand-Srivastava","year":"1997","journal-title":"J Hypertens"},{"issue":"32","key":"10.1016\/j.pharmthera.2004.08.011_bib2","doi-asserted-by":"crossref","first-page":"19324","DOI":"10.1074\/jbc.271.32.19324","article-title":"Cytoplasmic domain of natriuretic peptide receptor-C inhibits adenylyl cyclase. Involvement of a pertussis toxin-sensitive G protein","volume":"271","author":"Anand-Srivastava","year":"1996","journal-title":"J Biol Chem"},{"issue":"5 Pt 2","key":"10.1016\/j.pharmthera.2004.08.011_bib3","first-page":"H1907","article-title":"Mechanism of relaxations to C-type natriuretic peptide in veins","volume":"271","author":"Banks","year":"1996","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1016\/j.pharmthera.2004.08.011_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00005344-199807000-00002","article-title":"Gender and relaxation to C-type natriuretic peptide in porcine coronary arteries","volume":"32","author":"Barber","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2004.08.011_bib5","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1161\/01.HYP.31.3.802","article-title":"Low-dose C-type natriuretic peptide does not affect cardiac and renal function in humans","volume":"31","author":"Barletta","year":"1998","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.pharmthera.2004.08.011_bib6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00005344-199803000-00008","article-title":"Endothelium-independent relaxation and hyperpolarization to C-type natriuretic peptide in porcine coronary arteries","volume":"31","author":"Barton","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2004.08.011_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0014-5793(02)02998-8","article-title":"Processing of proendothelin-1 by members of the subtilisin-like pro-protein convertase family","volume":"524","author":"Blais","year":"2002","journal-title":"FEBS Lett"},{"issue":"8","key":"10.1016\/j.pharmthera.2004.08.011_bib8","first-page":"1173","article-title":"Characterization of human platelet receptors for atrial natriuretic peptide: evidence for clearance receptors","volume":"42","author":"Blaise","year":"1996","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"5","key":"10.1016\/j.pharmthera.2004.08.011_bib9","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/01.RES.77.5.906","article-title":"Regional expression of natriuretic peptide receptors during the formation of arterial neointima in the rabbit","volume":"77","author":"Brown","year":"1995","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2004.08.011_bib10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0008-6363(01)00283-8","article-title":"Relaxant effect of C-type natriuretic peptide involves endothelium and nitric oxide-cGMP system in rat coronary microvasculature","volume":"51","author":"Brunner","year":"2001","journal-title":"Cardiovasc Res"},{"issue":"8","key":"10.1016\/j.pharmthera.2004.08.011_bib11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0165-6147(02)02050-3","article-title":"EDHF: bringing the concepts together","volume":"23","author":"Busse","year":"2002","journal-title":"Trends Pharmacol Sci"},{"issue":"1 Pt 2","key":"10.1016\/j.pharmthera.2004.08.011_bib12","first-page":"R194","article-title":"ANF-C-receptor-mediated inhibition of aortic smooth muscle cell proliferation and thymidine kinase activity","volume":"266","author":"Cahill","year":"1994","journal-title":"Am J Physiol"},{"issue":"6","key":"10.1016\/j.pharmthera.2004.08.011_bib13","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/002215540205000606","article-title":"Natriuretic peptide system gene expression in human coronary arteries","volume":"50","author":"Casco","year":"2002","journal-title":"J Histochem Cytochem"},{"issue":"3","key":"10.1016\/j.pharmthera.2004.08.011_bib14","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1073\/pnas.0336365100","article-title":"Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor","volume":"100","author":"Chauhan","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.pharmthera.2004.08.011_bib15","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/00004872-199404000-00015","article-title":"Plasma brain natriuretic peptide and C-type natriuretic peptide in essential hypertension","volume":"12","author":"Cheung","year":"1994","journal-title":"J Hypertens"},{"issue":"6","key":"10.1016\/j.pharmthera.2004.08.011_bib16","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1161\/01.HYP.29.6.1296","article-title":"Shear stress augments expression of C-type natriuretic peptide and adrenomedullin","volume":"29","author":"Chun","year":"1997","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.pharmthera.2004.08.011_bib17","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1073\/pnas.071389098","article-title":"Dwarfism and early death in mice lacking C-type natriuretic peptide","volume":"98","author":"Chusho","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2 Pt 2","key":"10.1016\/j.pharmthera.2004.08.011_bib18","first-page":"R290","article-title":"C-type natriuretic peptide: a selective cardiovascular peptide","volume":"264","author":"Clavell","year":"1993","journal-title":"Am J Physiol"},{"issue":"6","key":"10.1016\/j.pharmthera.2004.08.011_bib19","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/01.CIR.93.6.1155","article-title":"C-type natriuretic peptide. An endogenous inhibitor of vascular angiotensin-converting enzyme activity","volume":"93","author":"Davidson","year":"1996","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.pharmthera.2004.08.011_bib20","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1074\/jbc.270.9.4668","article-title":"Natriuretic peptide receptor-B (guanylyl cyclase-B) mediates C-type natriuretic peptide relaxation of precontracted rat aorta","volume":"270","author":"Drewett","year":"1995","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharmthera.2004.08.011_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF03343802","article-title":"Possibility of age regulation of the natriuretic peptide C-receptor in human platelets","volume":"24","author":"Giannessi","year":"2001","journal-title":"J Endocrinol Invest"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2004.08.011_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0303-7207(99)00068-4","article-title":"Characterisation of the effects of natriuretic peptides upon ACTH secretion from the mouse pituitary","volume":"152","author":"Guild","year":"1999","journal-title":"Mol Cell Endocrinol"},{"issue":"3","key":"10.1016\/j.pharmthera.2004.08.011_bib23","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1006\/bbrc.1994.1166","article-title":"Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients","volume":"198","author":"Hama","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.pharmthera.2004.08.011_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1023\/A:1024255808831","article-title":"Cardiovascular effects of natriuretic peptides and their interrelation with endothelin-1","volume":"17","author":"Han","year":"2003","journal-title":"Cardiovasc Drugs Ther"},{"issue":"12","key":"10.1016\/j.pharmthera.2004.08.011_bib25","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0165-6147(97)01137-1","article-title":"Soluble guanylate cyclase: the forgotten sibling","volume":"18","author":"Hobbs","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2004.08.011_bib26","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/01.CIR.0000141802.29945.34","article-title":"Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia\/reperfusion injury: a novel cardioprotective role for endothelium-derived C-type natriuretic peptide","volume":"110","author":"Hobbs","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pharmthera.2004.08.011_bib27","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1161\/01.HYP.37.4.1179","article-title":"C-type natriuretic peptide-induced vasodilation is dependent on hyperpolarization in human forearm resistance vessels","volume":"37","author":"Honing","year":"2001","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.pharmthera.2004.08.011_bib28","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/j.1476-5381.1989.tb12558.x","article-title":"The effect of atrial natriuretic peptide on human isolated resistance arteries","volume":"97","author":"Hughes","year":"1989","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmthera.2004.08.011_bib29","doi-asserted-by":"crossref","first-page":"H1151","DOI":"10.1152\/ajpheart.2001.280.3.H1151","article-title":"Reciprocal regulation of cGMP-mediated vasorelaxation by soluble and particulate guanylate cyclases","volume":"280","author":"Hussain","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.pharmthera.2004.08.011_bib30","first-page":"S144","article-title":"C-type natriuretic peptide in chronic renal failure and its action in humans","volume":"55","author":"Igaki","year":"1996","journal-title":"Kidney Int Suppl"},{"issue":"17","key":"10.1016\/j.pharmthera.2004.08.011_bib31","doi-asserted-by":"crossref","first-page":"10079","DOI":"10.1073\/pnas.1632368100","article-title":"Four functionally distinct C-type natriuretic peptides found in fish reveal evolutionary history of the natriuretic peptide system","volume":"100","author":"Inoue","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.pharmthera.2004.08.011_bib32","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.CIR.0000047280.15244.EB","article-title":"Myocardial production of C-type natriuretic peptide in chronic heart failure","volume":"107","author":"Kalra","year":"2003","journal-title":"Circulation"},{"issue":"Pt 1","key":"10.1016\/j.pharmthera.2004.08.011_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1042\/bj2910083","article-title":"Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11","volume":"291","author":"Kenny","year":"1993","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.pharmthera.2004.08.011_bib34","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1210\/en.143.3.846","article-title":"Inhibition of cyclooxygenase-2 by natriuretic peptides","volume":"143","author":"Kiemer","year":"2002","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.pharmthera.2004.08.011_bib35","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/01.HYP.19.4.320","article-title":"C-type natriuretic peptide inhibits thrombin- and angiotensin II-stimulated endothelin release via cyclic guanosine 3\u2032,5\u2032-monophosphate","volume":"19","author":"Kohno","year":"1992","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.pharmthera.2004.08.011_bib36","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/01.RES.81.4.585","article-title":"Effect of natriuretic peptide family on the oxidized LDL-induced migration of human coronary artery smooth muscle cells","volume":"81","author":"Kohno","year":"1997","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2004.08.011_bib37","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000292333","article-title":"Effects of atrial natriuretic peptide and cyclic guanosine monophosphate on isolated human myometrial arteries preconstricted by endothelin-1","volume":"40","author":"Kublickiene","year":"1995","journal-title":"Gynecol Obstet Invest"},{"issue":"5","key":"10.1016\/j.pharmthera.2004.08.011_bib38","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJM199807303390507","article-title":"Natriuretic peptides","volume":"339","author":"Levin","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2004.08.011_bib39","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1146\/annurev.ph.54.030192.000303","article-title":"Receptors of atrial natriuretic factor","volume":"54","author":"Maack","year":"1992","journal-title":"Annu Rev Physiol"},{"issue":"4827","key":"10.1016\/j.pharmthera.2004.08.011_bib40","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1126\/science.2823385","article-title":"Physiological role of silent receptors of atrial natriuretic factor","volume":"238","author":"Maack","year":"1987","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.pharmthera.2004.08.011_bib41","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/sj.bjp.0705365","article-title":"Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling","volume":"139","author":"Madhani","year":"2003","journal-title":"Br J Pharmacol"},{"issue":"13","key":"10.1016\/j.pharmthera.2004.08.011_bib42","doi-asserted-by":"crossref","first-page":"7403","DOI":"10.1073\/pnas.96.13.7403","article-title":"The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system","volume":"96","author":"Matsukawa","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"10.1016\/j.pharmthera.2004.08.011_bib43","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1161\/01.CIR.0000014985.50017.6E","article-title":"Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide","volume":"105","author":"Ohno","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.pharmthera.2004.08.011_bib44","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1291\/hypres.25.727","article-title":"A single-nucleotide polymorphism in C-type natriuretic peptide gene may be associated with hypertension","volume":"25","author":"Ono","year":"2002","journal-title":"Hypertens Res"},{"issue":"7","key":"10.1016\/j.pharmthera.2004.08.011_bib45","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/01.HYP.8.7.606","article-title":"Synthetic atrial natriuretic factor does not dilate resistance-sized arteries","volume":"8","author":"Osol","year":"1986","journal-title":"Hypertension"},{"issue":"24","key":"10.1016\/j.pharmthera.2004.08.011_bib46","doi-asserted-by":"crossref","first-page":"14156","DOI":"10.1074\/jbc.271.24.14156","article-title":"Atrial natriuretic peptide inhibits mitogen-activated protein kinase through the clearance receptor. Potential role in the inhibition of astrocyte proliferation","volume":"271","author":"Prins","year":"1996","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.pharmthera.2004.08.011_bib47","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0895-7061(95)00435-1","article-title":"Relaxant effect of human brain natriuretic peptide on human artery and vein tissue","volume":"9","author":"Protter","year":"1996","journal-title":"Am J Hypertens"},{"issue":"11","key":"10.1016\/j.pharmthera.2004.08.011_bib48","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/01.RES.0000043631.25915.E6","article-title":"Local expression of C-type natriuretic peptide suppresses inflammation, eliminates shear stress-induced thrombosis, and prevents neointima formation through enhanced nitric oxide production in rabbit injured carotid arteries","volume":"91","author":"Qian","year":"2002","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.pharmthera.2004.08.011_bib49","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0006-291X(87)80299-1","article-title":"The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium","volume":"148","author":"Radomski","year":"1987","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"10.1016\/j.pharmthera.2004.08.011_bib50","doi-asserted-by":"crossref","first-page":"H1970","DOI":"10.1152\/ajpheart.00893.2003","article-title":"Effects of C-type natriuretic peptide on ionic currents in mouse sinoatrial node: a role for the NPR-C receptor","volume":"286","author":"Rose","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.pharmthera.2004.08.011_bib51","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis-an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.pharmthera.2004.08.011_bib52","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/j.1523-1755.2004.00598.x","article-title":"Local overexpression of C-type natriuretic peptide ameliorates vascular adaptation of porcine hemodialysis grafts","volume":"65","author":"Rotmans","year":"2004","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.pharmthera.2004.08.011_bib53","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ejcts.2003.07.013","article-title":"Perivascular application of C-type natriuretic peptide attenuates neointimal hyperplasia in experimental vein grafts","volume":"25","author":"Schachner","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"issue":"2","key":"10.1016\/j.pharmthera.2004.08.011_bib54","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4065\/74.2.126","article-title":"Presence of Dendroaspis natriuretic peptide-like immunoreactivity in human plasma and its increase during human heart failure","volume":"74","author":"Schirger","year":"1999","journal-title":"Mayo Clin Proc"},{"issue":"20","key":"10.1016\/j.pharmthera.2004.08.011_bib55","doi-asserted-by":"crossref","first-page":"13928","DOI":"10.1016\/S0021-9258(19)49658-0","article-title":"A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps)","volume":"267","author":"Schweitz","year":"1992","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.pharmthera.2004.08.011_bib56","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00005344-199609000-00008","article-title":"Renal and depressor activity of C-natriuretic peptide in conscious monkeys: effects of enzyme inhibitors","volume":"28","author":"Seymour","year":"1996","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmthera.2004.08.011_bib57","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00005344-199611000-00014","article-title":"The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation","volume":"28","author":"Shimokawa","year":"1996","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2004.08.011_bib58","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0304-3940(93)90789-N","article-title":"Central action of C-type natriuretic peptide on vasopressin secretion in conscious rats","volume":"159","author":"Shirakami","year":"1993","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"10.1016\/j.pharmthera.2004.08.011_bib59","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.regpep.2003.12.005","article-title":"Diverging vasorelaxing effects of C-type natriuretic peptide in renal resistance arteries and aortas of GC-A-deficient mice","volume":"119","author":"Steinmetz","year":"2004","journal-title":"Regul Pept"},{"issue":"4 Pt 2","key":"10.1016\/j.pharmthera.2004.08.011_bib60","first-page":"H1318","article-title":"Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma","volume":"263","author":"Stingo","year":"1992","journal-title":"Am J Physiol"},{"issue":"2","key":"10.1016\/j.pharmthera.2004.08.011_bib61","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0006-291X(90)92401-K","article-title":"C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain","volume":"168","author":"Sudoh","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"10.1016\/j.pharmthera.2004.08.011_bib62","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1210\/en.133.6.3038","article-title":"Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells-evidence for CNP as a novel autocrine\/paracrine regulator from endothelial cells","volume":"133","author":"Suga","year":"1993","journal-title":"Endocrinology"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2004.08.011_bib63","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1096-4959(01)00366-9","article-title":"Does the natriuretic peptide system exist throughout the animal and plant kingdom?","volume":"129","author":"Takei","year":"2001","journal-title":"Comp Biochem Physiol B Biochem Mol Biol"},{"issue":"10","key":"10.1016\/j.pharmthera.2004.08.011_bib64","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nrm934","article-title":"Furin at the cutting edge: from protein traffic to embryogenesis and disease","volume":"3","author":"Thomas","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"10.1016\/j.pharmthera.2004.08.011_bib65","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1210\/en.132.4.1872","article-title":"Detection of C-type natriuretic peptide (CNP) transcript in the rat heart and immune organs","volume":"132","author":"Vollmar","year":"1993","journal-title":"Endocrinology"},{"issue":"1 Pt 2","key":"10.1016\/j.pharmthera.2004.08.011_bib66","first-page":"H71","article-title":"Action of C-type natriuretic peptide in isolated canine arteries and veins","volume":"264","author":"Wei","year":"1993","journal-title":"Am J Physiol"},{"issue":"4 Pt 2","key":"10.1016\/j.pharmthera.2004.08.011_bib67","first-page":"H1618","article-title":"Further attenuation of endothelium-dependent relaxation imparted by natriuretic peptide receptor antagonism","volume":"277","author":"Wennberg","year":"1999","journal-title":"Am J Physiol"},{"issue":"4","key":"10.1016\/j.pharmthera.2004.08.011_bib68","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/sj.bjp.0704119","article-title":"Physiological antagonism of endothelin-1 in human conductance and resistance coronary artery","volume":"133","author":"Wiley","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.pharmthera.2004.08.011_bib69","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0735-1097(96)00241-0","article-title":"C-type natriuretic peptide-mediated coronary vasodilation: role of the coronary nitric oxide and particulate guanylate cyclase systems","volume":"28","author":"Wright","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmthera.2004.08.011_bib70","doi-asserted-by":"crossref","DOI":"10.1161\/01.HYP.0000105623.04382.C0","article-title":"Amino-terminal pro-C-type natriuretic peptide in heart failure","author":"Wright","year":"2003","journal-title":"Hypertension"},{"issue":"28","key":"10.1016\/j.pharmthera.2004.08.011_bib71","doi-asserted-by":"crossref","first-page":"25847","DOI":"10.1074\/jbc.M301223200","article-title":"Furin-mediated processing of Pro-C-type natriuretic peptide","volume":"278","author":"Wu","year":"2003","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.pharmthera.2004.08.011_bib72","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1073\/pnas.0538059100","article-title":"Significance and therapeutic potential of the natriuretic peptides\/cGMP\/cGMP-dependent protein kinase pathway in vascular regeneration","volume":"100","author":"Yamahara","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"10.1016\/j.pharmthera.2004.08.011_bib73","doi-asserted-by":"crossref","first-page":"8525","DOI":"10.1073\/pnas.150149097","article-title":"Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme","volume":"97","author":"Yan","year":"2000","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725804001287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725804001287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T21:55:20Z","timestamp":1624744520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725804001287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":73,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0163725804001287"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2004.08.011","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}